Swiss National Bank bought a new position in Genpact Limited (NYSE:G - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 332,900 shares of the business services provider's stock, valued at approximately $14,298,000. Swiss National Bank owned about 0.19% of Genpact as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently added to or reduced their stakes in G. JPMorgan Chase & Co. increased its position in Genpact by 192.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after buying an additional 2,060,595 shares during the period. Tandem Investment Advisors Inc. increased its position in Genpact by 390.5% in the 4th quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider's stock worth $91,480,000 after buying an additional 1,695,706 shares during the period. Victory Capital Management Inc. increased its position in Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after buying an additional 1,511,790 shares during the period. Geode Capital Management LLC increased its position in Genpact by 12.6% in the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock worth $148,142,000 after buying an additional 413,646 shares during the period. Finally, Empowered Funds LLC increased its position in shares of Genpact by 1,942.3% during the fourth quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider's stock valued at $13,975,000 after purchasing an additional 309,447 shares during the period. 96.03% of the stock is owned by institutional investors.
Genpact Price Performance
NYSE:G traded up $0.46 during trading hours on Friday, reaching $49.90. The company had a trading volume of 3,102,046 shares, compared to its average volume of 1,296,134. The stock has a 50-day moving average of $50.27 and a two-hundred day moving average of $44.66. Genpact Limited has a one year low of $30.23 and a one year high of $56.76. The firm has a market capitalization of $8.77 billion, a PE ratio of 17.57, a PEG ratio of 1.84 and a beta of 1.16. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a $0.17 dividend. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.36%. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is currently 23.94%.
Insiders Place Their Bets
In other news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.
Analyst Ratings Changes
G has been the topic of a number of research reports. Mizuho boosted their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Needham & Company LLC boosted their price objective on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, February 7th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $48.44.
Read Our Latest Analysis on Genpact
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report